Loading clinical trials...
Loading clinical trials...
Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients: Phase I-II Clinical Trial
Conditions
Interventions
EGCG
Locations
1
China
Shandong Cancer Hospital
Jinan, Shandong, China
Start Date
January 5, 2023
Primary Completion Date
December 31, 2023
Completion Date
December 31, 2025
Last Updated
May 30, 2023
NCT06778382
NCT05939687
NCT06121089
NCT05007340
NCT07190703
NCT06314971
Lead Sponsor
Shandong Cancer Hospital and Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions